DaVita DVA Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Other - Ancillary Services | $494.32M+20.0% | $564.02M+32.6% | $452.12M+21.0% | $482.85M+34.6% | $412.09M+21.6% | |
| Other Operating Segments with Intersegment | $497.61M+20.0% | $566.89M+31.8% | $454.89M+20.9% | $485.69M+34.0% | $414.82M+21.4% | |
| U.S.Dialysis And Related Lab Services | $2.92B+3.9% | —— | $2.97B+2.7% | $2.9B+2.4% | $2.81B— | |
| Other revenues by Business | ||||||
| Other - Ancillary Services | $108.51M+9.7% | $182.63M+14.9% | $85.88M-17.6% | $140.15M+43.8% | $98.95M-4.0% | |
| Other Operating Segments with Intersegment | $136.48M+19.2% | $214.19M+26.5% | $115.86M-2.5% | $166.69M+39.2% | $114.53M-6.8% | |
| Dialysis patient service revenues by Business | ||||||
| Other - Ancillary Services | $248.18M+18.3% | $241.46M+21.2% | $237.63M+21.1% | $224.94M+27.4% | $209.75M+43.9% | |
| Other Operating Segments with Intersegment | $357.84M+20.3% | $349.83M+36.7% | $336.26M+31.9% | $316.16M+32.3% | $297.57M+37.8% | |
| Segment, Expenditure, Addition to Long-Lived Assets by Business | ||||||
| Other - Ancillary Services | $13.58M-54.2% | $23.53M-26.2% | $33.34M+73.8% | $17.78M-3.9% | $29.67M+84.7% | |
| U.S.Dialysis And Related Lab Services | $88.44M-22.1% | —— | $132.74M+10.7% | $103.31M— | $113.59M— | |
| Foreign currency and other adjustments by Business | ||||||
| Other - Ancillary Services | $6.58M-83.5% | $0+100% | $10.02M— | $49.94M+273% | $39.95M+316% | |
| U.S.Dialysis | $0— | $0— | $0— | —— | —— | |
| D&A by Business | ||||||
| Other - Ancillary Services | $22.66M+15.9% | $23.23M+38.9% | $21.25M+29.0% | $17.92M+17.5% | $19.55M+37.4% | |
| U.S.Dialysis And Related Lab Services | $155.17M-1.1% | —— | $156.24M-8.4% | $156.78M-2.3% | $156.9M— | |
| Acquisitions by Business | ||||||
| Other - Ancillary Services | $9.54M+297% | —— | $68.09M+3,706% | —— | -$4.84M-114% | |
| U.S.Dialysis | $21.1M— | $5.01M-80.4% | —— | —— | —— | |
| Goodwill by Business | ||||||
| Other - Ancillary Services | $1.03B+15.7% | $1.02B+18.6% | $1.02B+43.8% | $943.17M+37.9% | $893.1M+25.4% | |
| U.S.Dialysis | $6.55B— | $6.53B+0.2% | $6.52B— | $6.52B— | —— | |
| Goodwill, Impaired, Accumulated Impairment Loss by Business | ||||||
| Other - Ancillary Services | $154.26M+5.2% | $156.74M+10.5% | $156.59M+4.2% | $156.58M+7.6% | $146.61M+0.1% | |
| U.S.Dialysis | $0— | —— | $0— | $0— | —— | |
| Goodwill, before accumulated impairment charges by Business | ||||||
| Other - Ancillary Services | $1.19B+14.2% | $1.17B+17.4% | $1.18B+36.9% | $1.1B+32.6% | $1.04B+21.0% | |
| U.S.Dialysis | $6.55B— | —— | $6.52B— | $6.52B— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does DaVita break its business down?
- DaVita (DVA) reports revenue by business across 3 parts — Other - Ancillary Services, Other Operating Segments with Intersegment and U.S.Dialysis And Related Lab Services. Each is extracted from the segment footnotes and tracked over time.
- Where does DaVita's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in DaVita's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
